Citation and commencement

1. This Order may be cited as the Misuse of Drugs Act 1971 (Amendment No. 2) Order 2010 and shall come into force on the second day after the day on which it is made.

Amendments to the Misuse of Drugs Act 1971

2. In Part 2 of Schedule 2 to the Misuse of Drugs Act 1971 (which specifies the drugs which are subject to control under that Act as Class B drugs) after paragraph 1(aa), insert–

"(ab) Any compound structurally derived from 2-aminopropan-1-one by substitution at the 1-position with any monocyclic, or fused-‘polycyclic ring system (not being a phenyl ring or alkylenedioxyphenyl ring system), whether or not the compound is further modified in any of the following ways, that is to say,

(i) by substitution in the ring system to any extent with alkyl, alkoxy, haloalkyl or halide substituents, whether or not further substituted in the ring system by one or more other univalent substituents;

(ii) by substitution at the 3-position with an alkyl substituent;

(iii) by substitution at the 2-‘amino nitrogen atom with alkyl or dialkyl groups, or by inclusion of the 2-‘amino nitrogen atom in a cyclic structure.".

EXPLANATORY NOTE

(This note is not part of the Order)

This Order adds a further group of cathinone derivatives (including naphthylpyrovalerone, commonly known as naphyrone) to Part 2 of Schedule 2 to the Misuse of Drugs Act 1971 which specifies drugs which are subject to control as Class B drugs under that Act.